The Clinical Management and Outcomes of Pelvic Neuroblastic Tumors

J Surg Res. 2020 May:249:8-12. doi: 10.1016/j.jss.2019.12.009. Epub 2020 Jan 7.

Abstract

Background: Pelvic neuroblastomas are rare and often present in children as massive tumors whose surgical resection can be associated with significant morbidity, given sacral nerve root involvement and close proximity to pelvic vascular structures. We sought to examine the characteristics of patients with pelvic neuroblastoma and the effect of extent of surgical resection on survival and surgical outcomes.

Materials and methods: After institutional review board approval, a retrospective chart review was performed at Children's Hospital Los Angeles from 2000 to 2018. Collected data included tumor location, size, image-defined risk factors histology, stage and risk classification, amplification of the oncogene MYCN or N-myc, use of preoperative chemotherapy, and extent of surgical resection. Outcome variables included postoperative complications and survival.

Results: Ten patients with primary pelvic neuroblastoma tumors were identified. The median age at diagnosis was 4.2 y (3 mo to 11 y). Four patients presented with a localized pelvic tumor (stage I or stage II) and underwent upfront tumor resection. Six patients presented with advanced disease (stage III or stage IV) and underwent neoadjuvant chemotherapy, followed by partial resection (30%-90% debulked). One patient experienced a complication: lower extremity hypotonia after tumor resection. One patient died from extensive metastatic disease for which no resection was attempted. The mean postoperative follow-up was 3.9 y with 90% overall survival.

Conclusions: Our data show that patients who undergo gross total resection for localized pelvic neuroblastoma or neoadjuvant chemotherapy, followed by partial resection for advanced disease have excellent survival. We recommend that small localized pelvic neuroblastoma undergo gross total resection and large unresectable tumors undergo neoadjuvant chemotherapy, followed by partial debulking resection to avoid neurovascular morbidity.

Keywords: Neuroblastoma; Pediatric; Pelvic neuroblastoma.

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Child
  • Child, Preschool
  • Cytoreduction Surgical Procedures / adverse effects
  • Cytoreduction Surgical Procedures / methods*
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Male
  • Neoadjuvant Therapy / methods*
  • Neoplasm Staging
  • Neuroblastoma / diagnosis
  • Neuroblastoma / mortality
  • Neuroblastoma / pathology
  • Neuroblastoma / therapy*
  • Pelvic Neoplasms / diagnosis
  • Pelvic Neoplasms / mortality
  • Pelvic Neoplasms / pathology
  • Pelvic Neoplasms / therapy*
  • Pelvis / blood supply
  • Pelvis / diagnostic imaging
  • Pelvis / surgery
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Survival Analysis
  • Tomography, X-Ray Computed
  • Treatment Outcome